BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10177613)

  • 1. The impact of the UK NHS purchaser-provider split on the 'rational' introduction of new medical technologies.
    Rosen R; Mays N
    Health Policy; 1998 Feb; 43(2):103-23. PubMed ID: 10177613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic appraisal in the British National Health Service: implications of recent developments.
    Henshall C; Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1615-23. PubMed ID: 8047919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational health economics: The key to accountable adoption of in vitro diagnostic technologies.
    Price CP; Wolstenholme J; McGinley P; St John A
    Health Serv Manage Res; 2018 Feb; 31(1):43-50. PubMed ID: 29084478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunity costs and local health service spending decisions: a qualitative study from Wales.
    Karlsberg Schaffer S; Sussex J; Hughes D; Devlin N
    BMC Health Serv Res; 2016 Mar; 16():103. PubMed ID: 27012523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge based commissioning: can a national clinical effectiveness policy be compatible with seeking local professional advice?
    Littlejohns P; Dumelow C; Griffiths S
    J Health Serv Res Policy; 1996 Jan; 1(1):28-34. PubMed ID: 10180842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
    Bryan S; Williams I; McIver S
    Health Econ; 2007 Feb; 16(2):179-93. PubMed ID: 16960851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care technology adoption and diffusion in a social context.
    Coyte PC; Holmes D
    Policy Polit Nurs Pract; 2007 Feb; 8(1):47-54. PubMed ID: 17470771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales.
    Birch S; Gafni A
    Health Econ; 2002 Apr; 11(3):185-91. PubMed ID: 11921316
    [No Abstract]   [Full Text] [Related]  

  • 9. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early warning of new health care technologies in the United Kingdom.
    Stevens A; Packer C; Robert G
    Int J Technol Assess Health Care; 1998; 14(4):680-6. PubMed ID: 9885458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Researcher-driven versus policy-driven economic appraisal of health technologies: the case of France.
    Moatti JP; Chanut C; Benech JM
    Soc Sci Med; 1994 Jun; 38(12):1625-33. PubMed ID: 8047920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decisions to adopt new technologies at the hospital level: insights from Israeli medical centers.
    Greenberg D; Peterburg Y; Vekstein D; Pliskin JS
    Int J Technol Assess Health Care; 2005; 21(2):219-27. PubMed ID: 15921062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adopting medical technologies and diagnostics recommended by NICE: the Health Technologies Adoption Programme.
    Chisholm S
    Ann R Coll Surg Engl; 2014 Jul; 96(5):400-1. PubMed ID: 24992441
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulating biotechnology: a rational-political model of policy development.
    Wiktorowicz M; Deber R
    Health Policy; 1997 May; 40(2):115-38. PubMed ID: 10167067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence, appropriateness, and technology assessment in cardiology: a case study of computed tomography.
    Redberg RF
    Health Aff (Millwood); 2007; 26(1):86-95. PubMed ID: 17211017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovation under wraps.
    Torjesen I
    Health Serv J; 2008 Feb; ():26-8. PubMed ID: 18396532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UK market today and tomorrow.
    Kreuzer M
    Med Device Technol; 2002 Dec; 13(10):39-40. PubMed ID: 12575530
    [No Abstract]   [Full Text] [Related]  

  • 18. Decision making in acquiring medical technologies in Israeli medical centers: a preliminary study.
    Greenberg D; Pliskin JS; Peterburg Y
    Int J Technol Assess Health Care; 2003; 19(1):194-201. PubMed ID: 12701951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health technology adoption and the politics of governance in the UK.
    Milewa T
    Soc Sci Med; 2006 Dec; 63(12):3102-12. PubMed ID: 16982120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of NICE technology appraisal in NHS rationing.
    Walker S; Palmer S; Sculpher M
    Br Med Bull; 2007; 81-82():51-64. PubMed ID: 17409119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.